Yusuke I. Kawamura
Saitama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 186 publications
ASO Visual Abstract: Prognostic Benefit of Sequential Locoregional Interventions During First-Line Systemic Therapy for Hepatocellular Carcinoma: Insights from Interaction Analysis of Lenvatinib and Atezolizumab/Bevacizumab.
Journal: Annals of surgical oncology
Published: August 01, 2026
Serum microRNA-122 Is Associated with the Therapeutic Response to Diet and Exercise Therapy in Patients with Steatotic Liver Disease.
Journal: Internal medicine (Tokyo, Japan)
Published: May 06, 2026
Prognostic Benefit of Sequential Locoregional Interventions During First-Line Systemic Therapy for Hepatocellular Carcinoma: Insights from Interaction Analysis of Lenvatinib and Atezolizumab/Bevacizumab.
Journal: Annals of surgical oncology
Published: April 24, 2026
Experimental Analyses of Spike Domains in Stress-Coated Grain-Oriented Electrical Steels (GOES).
Journal: Sensors (Basel, Switzerland)
Published: March 23, 2026
Magnetic Key Hole Technique (MKH) for Multi-Sensorics Local Tests of Soft Magnetic Laminations Under Defined Conditions of Induction.
Journal: Sensors (Basel, Switzerland)
Published: March 18, 2026
Passive Ankle Dorsiflexion and Single-Leg Balance Are Independently Associated with Locomotive Syndrome Severity in Community-Dwelling Older Adults: A Cross-Sectional Study.
Journal: Healthcare (Basel, Switzerland)
Published: January 28, 2026
Peripheral blood CD4+/CD8+ T cell ratio may have potential for predicting the treatment response of durvalumab plus tremelimumab therapy (STRIDE) for unresectable hepatocellular carcinoma: Preliminary report.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: February 16, 2025
Efficacy of Lenvatinib and Atezolizumab Bevacizumab Combination Therapy in Patients With Combined Hepatocellular-cholangiocarcinoma.
Journal: Anticancer research
Published: January 30, 2025
An Evaluation of the Most Convenient and Effective Procedure for Reducing the Loading Time of Epirubicin Into the Drug-Eluting Bead M1 (DC Bead M1™).
Journal: Cureus
Published: October 24, 2024
Functional characteristics of equilibrative nucleoside transporter 2 (ENT2/SLC29A2) for the transport of urate as a newly identified substrate.
Journal: Drug metabolism and pharmacokinetics
Published: August 01, 2024
Newly established borderline resectable 1 (BR1) category is one of the favorable candidates for selecting the use of multidisciplinary combination therapy in patients with advanced hepatocellular carcinoma treated with systemic therapy.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: July 16, 2024
Last Updated: 09/26/2026